Cancer biology deciphered by single-cell transcriptomic sequencing

Abstract

Tumors are complex ecosystems in which heterogeneous cancer cells interact with their microenvironment composed of diverse immune, endothelial, and stromal cells. Cancer biology had been studied using bulk genomic and gene expression profiling, which however mask the cellular diversity and average the variability among individual molecular programs. Recent advances in single-cell transcriptomic sequencing have enabled a detailed dissection of tumor ecosystems and promoted our understanding of tumorigenesis at single-cell resolution. In the present review, we discuss the main topics of recent cancer studies that have implemented singlecell RNA sequencing (scRNA-seq). To study cancer cells, scRNA-seq has provided novel insights into the cancer stem-cell model, treatment resistance, and cancer metastasis. To study the tumor microenvironment, scRNA-seq has portrayed the diverse cell types and complex cellular states of both immune and non-immune cells interacting with cancer cells, with the promise to discover novel targets for future immunotherapy.

Keywords

single-cell transcriptomic sequencing / tumor microenvironment / cancer

References

[1] Affara NI, Ruffell B, Medler TR, Gunderson AJ, Johansson M, Bornstein S, Bergsland E, Steinhoff M, Li Y, Gong Q(2014) B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas. Cancer Cell 25:809–821

[2] Aizarani N, Saviano A, Sagar, Mailly L, Durand S, Herman JS, Pessaux P, Baumert TF, Grün D(2019) A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 572:199–204

[3] Amend SR, Roy S, Brown JS, Pienta KJ(2016) Ecological paradigms to understand the dynamics of metastasis. Cancer Lett 380:237–242

[4] Azizi E, Carr AJ, Plitas G, Cornish AE, Konopacki C, Prabhakaran S, Nainys J, Wu K, Kiseliovas V, Setty M(2018) Single-cell map of in the breast tumor microenvironment. Cell 174:1293–1308. e1236

[5] Bartoschek M, Oskolkov N, Bocci M, Lovrot J, Larsson C, Sommarin M, Madsen CD, Lindgren D, Pekar G, Karlsson G(2018) Spatially and functionally distinct subclasses of breast cancerassociated fibroblasts revealed by single cell RNA sequencing. Nat Commun 9(1):5150

[6] Baryawno N, Przybylski D, Kowalczyk MS, Kfoury Y, Severe N, Gustafsson K, Kokkaliaris KD, Mercier F, Tabaka M, Hofree M(2019) A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia. Cell 177:1915–1932.e1916

[7] Baslan T, Hicks J(2017) Unravelling biology and shifting paradigms in cancer with single-cell sequencing. Nat Rev Cancer 17:557–569

[8] Baslan T, Kendall J, Rodgers L, Cox H, Riggs M, Stepansky A, Troge J, Ravi K, Esposito D, Lakshmi B(2012) Genomewide copy number analysis of single cells. Nat Protoc 7:1024–1041

[9] Berger MF, Mardis ER(2018) The emerging clinical relevance of genomics in cancer medicine. Nat Rev Clin Oncol 15:353–365

[10] Bi K, He MX, Bakouny Z, Kanodia A, Napolitano S, Wu J, Grimaldi G, Braun DA, Cuoco MS, Mayorga A(2021) Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell 39:649–661.e645

[11] Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC(2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24:541–550

[12] Brodbeck T, Nehmann N, Bethge A, Wedemann G, Schumacher U(2014) Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model. Mol Cancer 13:244

[13] Burrell RA, McGranahan N, Bartek J, Swanton C(2013) The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501:338–345

[14] Cancer Genome Atlas Research Network (2012a) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489:519–525

[15] Cancer Genome Atlas Research Network (2012b) Comprehensive genomic characterization of squamous cell lung cancers The Cancer Genome Atlas Research Network (vol 489, pg 519, 2012). Nature 491:288–288

[16] Cancer Genome Atlas Research Network (2014) Comprehensive molecular profiling of lung adenocarcinoma. Nature 511:543–550

[17] Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L(2016) Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med 374:135–145

[18] Chen DS, Mellman I(2017) Elements of cancer immunity and the cancer-immune set point. Nature 541:321–330

[19] Chen YC, Sahoo S, Brien R, Jung S, Humphries B, Lee W, Cheng YH, Zhang Z, Luker KE, Wicha MS(2019) Single-cell RNAsequencing of migratory breast cancer cells: discovering genes associated with cancer metastasis. Analyst 144:7296–7309

[20] Chung W, Eum HH, Lee HO, Lee KM, Lee HB, Kim KT, Ryu HS, Kim S, Lee JE, Park YH(2017) Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun 8:15081

[21] Cillo AR, Kurten CHL, Tabib T, Qi Z, Onkar S, Wang T, Liu A, Duvvuri U, Kim S, Soose RJ(2020) Immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity 52:183–199. e189

[22] Clevers H(2011) The cancer stem cell: premises, promises and challenges. Nat Med 17:313–319

[23] de Groot AE, Roy S, Brown JS, Pienta KJ, Amend SR(2017) Revisiting seed and soil: examining the primary tumor and cancer cell foraging in metastasis. Mol Cancer Res 15:361–370

[24] Dean M, Fojo T, Bates S(2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275–284

[25] Dominguez CX, Muller S, Keerthivasan S, Koeppen H, Hung J, Gierke S, Breart B, Foreman O, Bainbridge TW, Castiglioni A(2020) Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discov 10:232–253

[26] Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, Teinor JA, Belleau P, Biffi G, Lucito MS(2019) Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov 9:1102–1123

[27] Engblom C, Pfirschke C, Pittet MJ(2016) The role of myeloid cells in cancer therapies. Nat Rev Cancer 16:447–462

[28] Fearon ER, Vogelstein B(1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767

[29] Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND, Neftel C, Frank N, Pelton K, Hebert CM(2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360:331–335

[30] Garraway LA, Lander ES(2013) Lessons from the cancer genome. Cell 153:17–37

[31] George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, Leenders F, Lu X, Fernandez-Cuesta L, Bosco G(2015) Comprehensive genomic profiles of small cell lung cancer. Nature 524:47–53

[32] Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A(2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892

[33] Giustacchini A, Thongjuea S, Barkas N, Woll PS, Povinelli BJ, Booth CAG, Sopp P, Norfo R, Rodriguez-Meira A, Ashley N(2017) Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia. Nat Med 23:692–702

[34] Guo W, Li L, He J, Liu Z, Han M, Li F, Xia X, Zhang X, Zhu Y, Wei Y(2020) Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips. Nat Genet 52:908–918

[35] Guo X, Zhang Y, Zheng L, Zheng C, Song J, Zhang Q, Kang B, Liu Z, Jin L, Xing R(2018) Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med 24:978–985

[36] Hashimshony T, Senderovich N, Avital G, Klochendler A, de Leeuw Y, Anavy L, Gennert D, Li SQ, Livak KJ, Rozenblatt-Rosen O(2016) CEL-Seq2: sensitive highly-multiplexed single-cell RNASeq. Genome Biol 17:77

[37] Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313–323

[38] Hollern DP, Xu N, Thennavan A, Glodowski C, Garcia-Recio S, Mott KR, He X, Garay JP, Carey-Ewend K, Marron D(2019) B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer. Cell 179:1191–1206.e1121

[39] Horning AM, Wang Y, Lin CK, Louie AD, Jadhav RR, Hung CN, Wang CM, Lin CL, Kirma NB, Liss MA(2018) Single-cell RNA-seq reveals a subpopulation of prostate cancer cells with enhanced cell-cycle-related transcription and attenuated androgen response. Cancer Res 78:853–864

[40] Jan M, Snyder TM, Corces-Zimmerman MR, Vyas P, Weissman IL, Quake SR, Majeti R(2012) Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med.

[41] Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR(2018) A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell 175:984–997.e924

[42] Jin S, Li R, Chen MY, Yu C, Tang LQ, Liu YM, Li JP, Liu YN, Luo YL, Zhao Y(2020) Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma. Cell Res 30:950–965

[43] Jordan NV, Bardia A, Wittner BS, Benes C, Ligorio M, Zheng Y, Yu M, Sundaresan TK, Licausi JA, Desai R(2016) HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature 537:102–106

[44] Just NP, Finlay-Schultz J, Gillen AE, Cittelly DM, Wellberg EA, Horwitz KB, Kabos P, Sartorius CA(2018) Single-cell RNA sequencing defines regulatory networks in ER plus breast cancer organ-specific metastases. Cancer Res.

[45] Kalluri R(2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16:582–598

[46] Kim KT, Lee HW, Lee HO, Song HJ, Jeong DE, Shin S, Kim H, Shin Y, Nam DH, Jeong BC(2016) Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma. Genome Biol 17:80

[47] Klein-Goldberg A, Maman S, Witz IP(2014) The role played by the microenvironment in site-specific metastasis. Cancer Lett 352:54–58

[48] Klein AM, Mazutis L, Akartuna I, Tallapragada N, Veres A, Li V, Peshkin L, Weitz DA, Kirschner MW(2015) Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell 161:1187–1201

[49] Kreso A, Dick JE(2014) Evolution of the cancer stem cell model. Cell Stem Cell 14:275–291

[50] Kurtulus S, Madi A, Escobar G, Klapholz M, Nyman J, Christian E, Pawlak M, Dionne D, Xia JR, Rozenblatt-Rosen O(2019) Checkpoint blockade immunotherapy induces dynamic changes in PD-1(−)CD8(+) tumor-infiltrating T cells. Immunity 50:181

[51] Lambert AW, Pattabiraman DR, Weinberg RA(2017) Emerging biological principles of metastasis. Cell 168:670–691

[52] Lambrechts D, Wauters E, Boeckx B, Aibar S, Nittner D, Burton O, Bassez A, Decaluwe H, Pircher A, Van den Eynde K(2018) Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med 24:1277

[53] Lavin Y, Kobayashi S, Leader A, Amir ED, Elefant N, Bigenwald C, Remark R, Sweeney R, Becker CD, Levine JH(2017) Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell 169:750–765.e717

[54] Lawson DA, Bhakta NR, Kessenbrock K, Prummel KD, Yu Y, Takai K, Zhou A, Eyob H, Balakrishnan S, Wang CY(2015) Singlecell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature 526:131–135

[55] Leruste A, Tosello J, Ramos RN, Tauziede-Espariat A, Brohard S, Han ZY, Beccaria K, Andrianteranagna M, Caudana P, Nikolic J(2019) Clonally expanded T cells reveal immunogenicity of rhabdoid tumors. Cancer Cell 36:597

[56] Li H, Courtois ET, Sengupta D, Tan Y, Chen KH, Goh JJL, Kong SL, Chua C, Hon LK, Tan WS(2017) Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet 49:708–718

[57] Li HJ, van der Leun AM, Yofe I, Lubling Y, Gelbard-Solodkin D, van Akkooi ACJ, van den Braber M, Rozeman EA, Haanen JBAG, Blank CU(2019) Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell 176:775

[58] Ligorio M, Sil S, Malagon-Lopez J, Nieman LT, Misale S, Di Pilato M, Ebright RY, Karabacak MN, Kulkarni AS, Liu A(2019) Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer. Cell 178:160

[59] Lu Y, Zhao Q, Liao JY, Song E, Xia Q, Pan J, Li Y, Li J, Zhou B, Ye Y(2020) Complement signals determine opposite effects of B cells in chemotherapy-induced immunity. Cell 180(6):1081–1097

[60] Maley CC, Aktipis A, Graham TA, Sottoriva A, Boddy AM, Janiszewska M, Silva AS, Gerlinger M, Yuan YY, Pienta KJ(2017) Classifying the evolutionary and ecological features of neoplasms. Nat Rev Cancer 17:605–619

[61] Maman S, Witz IP(2018) A history of exploring cancer in context. Nat Rev Cancer 18:359–376

[62] McGranahan N, Swanton C(2017) Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168:613–628

[63] Merlo LMF, Pepper JW, Reid BJ, Maley CC(2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6:924–935

[64] Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, Singh B, Rosenblum MD, Fuchs E (2019) Adaptive immune resistance emerges from tumor-initiating stem cells. Cell 177:1172–1186. e1114

[65] Micallef L, Vedrenne N, Billet F, Coulomb B, Darby IA, Desmouliere A(2012) The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair 5:S5

[66] Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT, Desai R, Fox DB, Brannigan BW, Trautwein J(2015) RNASeq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science 349:1351–1356

[67] Muller S, Kohanbash G, Liu SJ, Alvarado B, Carrera D, Bhaduri A, Watchmaker PB, Yagnik G, Di Lullo E, Malatesta M(2017) Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol 18:234

[68] Murugaesu N, Wilson GA, Birkbak NJ, Watkins T, McGranahan N, Kumar S, Abbassi-Ghadi N, Salm M, Mitter R, Horswell S(2015) Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy. Cancer Discov 5:821–831

[69] Nakagawa H, Fujita M(2018) Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Sci 109:513–522

[70] Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D(2011) Tumour evolution inferred by single-cell sequencing. Nature 472:90–94

[71] Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM(2019) An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178:835–849.e821

[72] Orimo A, Weinberg RA(2006) Stromal fibroblasts in cancer—a novel tumor-promoting cell type. Cell Cycle 5:1597–1601

[73] Pantel K, Brakenhoff RH(2004) Dissecting the metastatic cascade. Nat Rev Cancer 4:448–456

[74] Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, Van Keymeulen A, Brown D, Moers V, Lemaire S(2018) Identification of the tumour transition states occurring during EMT. Nature 556:463–468

[75] Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL(2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344:1396–1401

[76] Paulson KG, Voillet V, McAfee MS, Hunter DS, Wagener FD, Perdicchio M, Valente WJ, Koelle SJ, Church CD, Vandeven N(2018) Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Nat Commun 9:3868

[77] Picelli S, Bjorklund AK, Faridani OR, Sagasser S, Winberg G, Sandberg R(2013) Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat Methods 10:1096–1098

[78] Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, Rodman C, Luo CL, Mroz EA, Emerick KS(2017) Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171:1611–1624.e1624

[79] Pylayeva-Gupta Y, Das S, Handler JS, Hajdu CH, Coffre M, Koralov SB, Bar-Sagi D(2016) IL35-producing B cells promote the development of pancreatic neoplasia. Cancer Discov 6:247–255

[80] Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, Karras P, Brown D, Chang YH, Debiec-Rychter M(2018) Toward minimal residual disease-directed therapy in melanoma. Cell 174:843

[81] Ramskold D, Luo SJ, Wang YC, Li R, Deng QL, Faridani OR, Daniels GA, Khrebtukova I, Loring JF, Laurent LC(2012) Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol 30:777–782

[82] Ren X, Kang B, Zhang Z(2018) Understanding tumor ecosystems by single-cell sequencing: promises and limitations. Genome Biol 19:211

[83] Salmon H, Idoyaga J, Rahman A, Leboeuf M, Remark R, Jordan S, Casanova-Acebes M, Khudoynazarova M, Agudo J, Tung N(2016) Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity 44:924–938

[84] Savage P, Blanchet-Cohen A, Revil T, Badescu D, Saleh SMI, Wang YC, Zuo D, Liu L, Bertos NR, Munoz-Ramos V(2017) A targetable EGFR-dependent tumor-initiating program in breast cancer. Cell Rep 21:1140–1149

[85] Savas P, Virassamy B, Ye C, Salim A, Mintoff CP, Caramia F, Salgado R, Byrne DJ, Teo ZL, Dushyanthen S(2018) Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat Med 24:986–993

[86] Sceneay J, Chow MT, Chen A, Halse HM, Wong CSF, Andrews DM, Sloan EK, Parker BS, Bowtell DD, Smyth MJ(2012) Primary tumor hypoxia recruits CD11b(+)/Ly6C(med)/Ly6G(+) immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res 72:3906–3911

[87] Singer M, Wang C, Cong L, Marjanovic ND, Kowalczyk MS, Zhang H, Nyman J, Sakuishi K, Kurtulus S, Gennert D(2016) A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells. Cell 166:1500–1511.e1509

[88] Song QQ, Hawkins GA, Wudel L, Chou PC, Forbes E, Pullikuth AK, Liu L, Jin GX, Craddock L, Topaloglu U(2019) Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq. Cancer Med US 8:3072–3085

[89] Sottoriva A, Kang H, Ma Z, Graham TA, Salomon MP, Zhao J, Marjoram P, Siegmund K, Press MF, Shibata D(2015) A Big Bang model of human colorectal tumor growth. Nat Genet 47:209–216

[90] Suva ML, Tirosh I(2019) Single-cell RNA sequencing in cancer: lessons learned and emerging challenges. Mol Cell 75:7–12

[91] Swanton C, Govindan R(2016) Clinical implications of genomic discoveries in lung cancer. N Engl J Med 374:1864–1873

[92] Szczerba BM, Castro-Giner F, Vetter M, Krol I, Gkountela S, Landin J, Scheidmann MC, Donato C, Scherrer R, Singer J(2019) Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 566:553

[93] Tang FC, Barbacioru C, Wang YZ, Nordman E, Lee C, Xu NL, Wang XH, Bodeau J, Tuch BB, Siddiqui A(2009) mRNA-Seq whole-transcriptome analysis of a single cell. Nat Methods 6:377–386

[94] Tirosh I, Izar B, Prakadan SM, Wadsworth MH II, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G(2016a) Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352:189–196

[95] Tirosh I, Suva ML(2019) Deciphering human tumor biology by single-cell expression profiling. Annu Rev Cancer Biol 3:151–166

[96] Tirosh I, Venteicher AS, Hebert C, Escalante LE, Patel AP, Yizhak K, Fisher JM, Rodman C, Mount C, Filbin MG(2016b) Singlecell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 539:309–313

[97] Turajlic S, Sottoriva A, Graham T, Swanton C(2019) Resolving genetic heterogeneity in cancer. Nat Rev Genet 20:404–416

[98] Turajlic S, Swanton C(2017) Implications of cancer evolution for drug development. Nat Rev Drug Discov 16:441–442

[99] Valkenburg KC, de Groot AE, Pienta KJ(2018) Targeting the tumour stroma to improve cancer therapy. Nat Rev Clin Oncol 15:366–381

[100] van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S, Verga JA, Stephansky J, Pastika TJ, Lombardi Story J(2019) Single-cell RNA-Seq reveals AML hierarchies relevant to disease progression and immunity. Cell 176:1265–1281.e1224

[101] Velten L, Story BA, Hernandez-Malmierca P, Raffel S, Leonce DR, Milbank J, Paulsen M, Demir A, Szu-Tu C, Fromel R(2021) Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics. Nat Commun 12:1366

[102] Venteicher AS, Tirosh I, Hebert C, Yizhak K, Neftel C, Filbin MG, Hovestadt V, Escalante LE, Shaw ML, Rodman C(2017) Decoupling genetics, lineages, and microenvironment in IDHmutant gliomas by single-cell RNA-seq. Science.

[103] Vermeulen L, Snippert HJ(2014) Stem cell dynamics in homeostasis and cancer of the intestine. Nat Rev Cancer 14:468–480

[104] Vladoiu MC, El-Hamamy I, Donovan LK, Farooq H, Holgado BL, Sundaravadanam Y, Ramaswamy V, Hendrikse LD, Kumar S, Mack SC(2019) Childhood cerebellar tumours mirror conserved fetal transcriptional programs. Nature 572:67–73

[105] Wan LL, Pantel K, Kang YB(2013) Tumor metastasis: moving new biological insights into the clinic. Nat Med 19:1450–1464

[106] Wang QH, Hu X, Muller F, Kim H, Squatrito M, Mikkelsen T, Scarpace L, Barthel F, Lin YH, Satani N(2016) Tumor evolution of glioma intrinsic gene expression subtype associates with immunological changes in the microenvironment. Neuro-Oncology 18:202–202

[107] Weinberg RA(2002) Cancer Biology and Therapy: the road ahead. Cancer Biol Ther 1:3

[108] Weis SM, Cheresh DA(2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17:1359–1370

[109] Williams MJ, Werner B, Barnes CP, Graham TA, Sottoriva A(2016) Identification of neutral tumor evolution across cancer types. Nat Genet 48:238–244

[110] Xing X, Yang F, Huang Q, Guo H, Li J, Qiu M, Bai F, Wang J(2021) Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing. Sci Adv.

[111] Yamamoto R, Morita Y, Ooehara J, Hamanaka S, Onodera M, Rudolph KL, Ema H, Nakauchi H(2013) Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell 154:1112–1126

[112] Yost KE, Satpathy AT, Wells DK, Qi YY, Wang CL, Kageyama R, McNamara KL, Granja JM, Sarin KY, Brown RA(2019) Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat Med 25:1251

[113] Young MD, Mitchell TJ, Braga FAV, Tran MGB, Stewart BJ, Ferdinand JR, Collord G, Botting RA, Popescu DM, Loudon KW(2018) Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science 361:594

[114] Zhang L, Yu X, Zheng L, Zhang Y, Li Y, Fang Q, Gao R, Kang B, Zhang Q, Huang JY(2018) Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564:268–272

[115] Zhang L, Zhang Z(2019) Recharacterizing tumor-infiltrating lymphocytes by single-cell RNA sequencing. Cancer Immunol Res 7:1040–1046

[116] Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, Modak M, Carotta S, Haslinger C, Kind D(2019) Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179:829–845.e820

[117] Zheng C, Zheng L, Yoo JK, Guo H, Zhang Y, Guo X, Kang B, Hu R, Huang JY, Zhang Q(2017a) Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169:1342–1356.e1316

[118] Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, Ziraldo SB, Wheeler TD, McDermott GP, Zhu J(2017b) Massively parallel digital transcriptional profiling of single cells. Nat Commun 8:14049

[119] Zheng H, Pomyen Y, Hernandez MO, Li C, Livak F, Tang W, Dang H, Greten TF, Davis JL, Zhao Y(2018) Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma. Hepatology 68:127–140

RIGHTS & PERMISSIONS

The Author(s)